Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease

Study Title
Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease
Teva Identifier
TVP - 1012/233
ClinicalTrials.gov Identifier
NCT00203138
Study Status
Completed
Trial Condition(s)
Parkinson's Disease
Interventions
Drug: rasagiline mesylate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
35 Years and older
Trial Duration
06/01/2004 - 12/01/2006
Phase
Phase 3

Study Type

Interventional